Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid

To target breast cancer (BC), epigenetic modulation could be a promising therapy strategy due to its role in the genesis, growth, and metastases of BC. Valproic acid (VPA) is a well-known histone deacetylase inhibitor (HDACi), which due to its epigenetic focus needs to be studied in depth to underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Estrada-Pérez, Alan Rubén, Rosales-Hernández, Martha Cecilia, García-Vázquez, Juan Benjamín, Bakalara, Norbert, Fromager, Benedicte, Correa-Basurto, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910739/
https://www.ncbi.nlm.nih.gov/pubmed/35269790
http://dx.doi.org/10.3390/ijms23052645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910739/
https://www.ncbi.nlm.nih.gov/pubmed/35269790
http://dx.doi.org/10.3390/ijms23052645

Ejemplares similares